Literature DB >> 17049722

Friedreich's ataxia: a clinical and genetic analysis.

P Leema Reddy1, Raji P Grewal.   

Abstract

We report a patient with genetically confirmed Friedreich's ataxia (FRDA) who developed a previously unreported feature of a mixed sleep apnea. Initial mutation analysis, by PCR, of the parental frataxin alleles showed an apparent de novo mutation in the maternal germline. Further investigation using Southern blot analysis showed that the mother did carry an expanded mutant frataxin allele. Based upon published data, FRDA resulting from at least one allelic spontaneous expansion mutation is rare with a frequency of less than 1/1,000,000. The presence of such a mutation should be confirmed by Southern blot analysis. Our patient expands the neurological features of FRDA to include sleep apnea. The genetic analysis of the family demonstrates the importance of Southern blot analysis for accurate genotyping which, in turn, has implications for genetic counseling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049722     DOI: 10.1016/j.clineuro.2006.09.003

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

1.  Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.

Authors:  R Mark Payne; P Melanie Pride; Clifford M Babbey
Journal:  Pediatr Cardiol       Date:  2011-03-01       Impact factor: 1.655

2.  The Heart in Friedreich's Ataxia: Basic Findings and Clinical Implications.

Authors:  R Mark Payne
Journal:  Prog Pediatr Cardiol       Date:  2011-05

Review 3.  Cardiomyopathy in Friedreich ataxia: clinical findings and research.

Authors:  R Mark Payne; Gregory R Wagner
Journal:  J Child Neurol       Date:  2012-07-04       Impact factor: 1.987

Review 4.  Friedreich ataxia: clinical features and new developments.

Authors:  Medina Keita; Kellie McIntyre; Layne N Rodden; Kim Schadt; David R Lynch
Journal:  Neurodegener Dis Manag       Date:  2022-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.